Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.Published in:Clinical & Experimental Medicine, 2018, v. 18, n. 4, p. 473, doi. 10.1007/s10238-018-0519-0By:Wang, Xia;Zheng, Peilin;Huang, Gan;Yang, Lin;Zhou, ZhiguangPublication type:Article